Paxil™ CR

• Approved February 1999 in 12.5 mg and 25 mg strengths - more strength expected

• Anticipated launch late 2000

• Significant royalty flows expected

• 7th largest pharmaceutical product in the world

• 1998 revenues of $1.8 billion, growing at 36%

Previous slide

Next slide

Back to first slide

View graphic version